Press "Enter" to skip to content

New patent for Esperion Theraps drug NEXLIZET

1
Copyright © DrugPatentWatch. Originally published at New patent for Esperion Theraps drug NEXLIZET

Annual Drug Patent Expirations for NEXLIZET
Annual Drug Patent Expirations for NEXLIZET

Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this drug.

NEXLIZET drug price trends.

This drug has twenty patent family members in thirteen countries.

The generic ingredient in NEXLIZET is bempedoic acid; ezetimibe. Additional details are available on the bempedoic acid; ezetimibe profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Esperion Theraps drug NEXLIZET
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions